374 related articles for article (PubMed ID: 23029542)
1. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
2. Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation.
Gui J; Chen R; Xu W; Xiong S
J Cell Mol Med; 2015 Apr; 19(4):850-64. PubMed ID: 25728713
[TBL] [Abstract][Full Text] [Related]
3. Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression.
Chen J; Wang Z; Wu T
Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1826-34. PubMed ID: 23374452
[TBL] [Abstract][Full Text] [Related]
4. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
5. LncGBP9 knockdown alleviates myocardial inflammation and apoptosis in mice with acute viral myocarditis via suppressing NF-κB signaling pathway.
Xue Y; Zhang J; Ke J; Zeng L; Cheng K; Han X; Chen F; Chen F
Inflamm Res; 2022 Dec; 71(12):1559-1576. PubMed ID: 36301340
[TBL] [Abstract][Full Text] [Related]
6. Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway.
Song Y; Ge W; Cai H; Zhang H
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):560-9. PubMed ID: 24057864
[TBL] [Abstract][Full Text] [Related]
7. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
8. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
9. Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-κB/p65.
Gao X; Xuan Y; Zhou Z; Chen C; Wen Wang D; Wen Z
Int Immunopharmacol; 2024 May; 133():112073. PubMed ID: 38636372
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
11. Role of neutrophils in CVB3 infection and viral myocarditis.
Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M
J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
13. CARD9 mediates T cell inflammatory response in Coxsackievirus B3-induced acute myocarditis.
Sun C; Zhang X; Yu Y; Li Z; Xie Y
Cardiovasc Pathol; 2020; 49():107261. PubMed ID: 32771878
[TBL] [Abstract][Full Text] [Related]
14. A20 (TNFAIP3) alleviates viral myocarditis through ADAR1/miR-1a-3p-dependent regulation.
Li B; Xie X
BMC Cardiovasc Disord; 2022 Jan; 22(1):10. PubMed ID: 35034631
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
16. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
[TBL] [Abstract][Full Text] [Related]
17. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice.
Zhang H; Song Y; Zhang Z
Am J Med Sci; 2012 Sep; 344(3):206-10. PubMed ID: 22197982
[TBL] [Abstract][Full Text] [Related]
19. Low-intensity pulsed ultrasound attenuates cardiac inflammation of CVB3-induced viral myocarditis via regulation of caveolin-1 and MAPK pathways.
Zheng C; Wu SM; Lian H; Lin YZ; Zhuang R; Thapa S; Chen QZ; Chen YF; Lin JF
J Cell Mol Med; 2019 Mar; 23(3):1963-1975. PubMed ID: 30592150
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]